What is the recommended dosage of levothyroxine (T4) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levothyroxine Dosage for Adults

Initial Dosing Strategy

For adults under 70 years without cardiac disease, start with the full replacement dose of 1.6 mcg/kg/day (typically 100-150 mcg/day for most patients), as this approach safely achieves euthyroidism faster without increasing cardiac risk. 1, 2

  • Most women require 100-150 mcg/day, while most men require 100-150 mcg/day, with a median dose of 125 mcg/day across all patients 3, 4
  • The full replacement dose can be initiated immediately in younger patients without cardiac comorbidities 1, 2

Age and Cardiac Risk-Based Dosing

For patients over 70 years or those with cardiac disease/multiple comorbidities, start with a lower dose of 25-50 mcg/day and titrate more slowly every 6-8 weeks to avoid cardiac decompensation. 5, 1, 2

  • Elderly patients require approximately one-third less levothyroxine than younger patients, with mean replacement doses around 110 mcg/day 6
  • Lower starting doses minimize risk of exacerbating angina, arrhythmias, or precipitating cardiac events 5, 2

Dose Titration Protocol

Adjust levothyroxine by 12.5-25 mcg increments every 4-6 weeks based on TSH and free T4 levels until the patient is euthyroid. 1, 2

  • For younger patients without cardiac disease, use 25 mcg increments 5, 1
  • For elderly or cardiac patients, use smaller 12.5 mcg increments to avoid cardiac complications 5, 1
  • Larger adjustments risk overtreatment and should be avoided 5, 1
  • The peak therapeutic effect of a given dose may not be attained for 4-6 weeks 2

Monitoring Guidelines

Check TSH every 6-8 weeks during dose titration, then every 6-12 months once stable. 5, 1, 2

  • For primary hypothyroidism, titrate until TSH normalizes to 0.5-4.5 mIU/L and the patient is clinically euthyroid 5, 1, 2
  • Free T4 helps interpret ongoing abnormal TSH during therapy, as TSH may lag behind normalization 5, 1
  • For secondary or tertiary hypothyroidism, TSH is unreliable—use serum free-T4 level and titrate until it reaches the upper half of the normal range 2

Special Population Considerations

For pregnant patients, increase the levothyroxine dose by 25-50% above pre-pregnancy requirements as soon as pregnancy is confirmed. 5, 1

  • Inadequate treatment increases risk of preeclampsia, low birth weight, and neurodevelopmental effects in offspring 5
  • Measure TSH and free T4 as soon as pregnancy is confirmed and during each trimester 2

For patients with TSH >10 mIU/L, initiate treatment regardless of symptoms, as this threshold carries approximately 5% annual risk of progression to overt hypothyroidism. 5, 1

Administration Timing

Administer levothyroxine on an empty stomach, at least 30-60 minutes before breakfast, to maximize absorption. 2, 7

  • Taking levothyroxine before dinner instead of before breakfast results in significantly reduced therapeutic efficacy, with TSH increasing by 1.47 µIU/mL 7
  • Administer at least 4 hours before or after drugs that interfere with absorption 2

Critical Pitfalls to Avoid

Never start levothyroxine before ruling out adrenal insufficiency in patients with suspected central hypothyroidism, as this can precipitate life-threatening adrenal crisis. 5, 1

  • Approximately 25% of patients are unintentionally overtreated with TSH suppression, increasing risks for atrial fibrillation, osteoporosis, fractures, and cardiac complications 5, 1
  • Prolonged TSH suppression (<0.1 mIU/L) increases risk for atrial fibrillation (especially in elderly), osteoporosis, and cardiovascular mortality 5, 1
  • If TSH becomes suppressed, reduce dose by 12.5-25 mcg immediately 5, 1

Treatment Goals

Target TSH of 0.5-4.5 mIU/L for primary hypothyroidism; TSH suppression (<0.1 mIU/L) indicates overtreatment requiring immediate dose reduction. 5, 1

  • Overtreatment occurs in 14-21% of treated patients and carries significant morbidity risks 5, 1
  • Dosages greater than 200 mcg/day are seldom required, and inadequate response to doses greater than 300 mcg/day may indicate poor compliance, malabsorption, or drug interactions 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.